http://hl7.eu/fhir/ig/gravitate-health/Bundle/bundlepackageleaflet-en-29436a85dac3ea374adb3fa64cfd2578
type: Bundle
node role: treeRoot
meta:
  profile:
    v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Bundle-uv-epi
    l: Bundle-uv-epi
language:
  v: en
identifier:
  system:
    v: https://www.gravitatehealth.eu/sid/doc
    l: doc
  value:
    v: 79963
type:
  v: document
timestamp:
  v: 2023-06-27T10:09:22Z
entry:
  full url:
    v: http://hl7.eu/fhir/ig/gravitate-health/Composition/composition-en-af8d2f6e4772c29a8ef9fbb165e80d28
entry:
  full url:
    v: http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-hipricoarkopharma-hypericumperforatuml
    l: ingredient-for-hipricoarkopharma-hypericumperforatuml
  resource: ingredient-for-hipricoarkopharma-hypericumperforatuml
entry:
  full url:
    v: http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-hipricoarkopharma-microcrystallinecellulose
    l: ingredient-for-hipricoarkopharma-microcrystallinecellulose
  resource: ingredient-for-hipricoarkopharma-microcrystallinecellulose
entry:
  full url:
    v: http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-hipricoarkopharma-magnesiumstearate
    l: ingredient-for-hipricoarkopharma-magnesiumstearate
  resource: ingredient-for-hipricoarkopharma-magnesiumstearate
entry:
  full url:
    v: http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-hipricoarkopharma-colloidalhydrophobicsilica
    l: ingredient-for-hipricoarkopharma-colloidalhydrophobicsilica
  resource: ingredient-for-hipricoarkopharma-colloidalhydrophobicsilica
entry:
  full url:
    v: http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-hipricoarkopharma-maltodextrin
    l: ingredient-for-hipricoarkopharma-maltodextrin
  resource: ingredient-for-hipricoarkopharma-maltodextrin
entry:
  full url:
    v: http://hl7.eu/fhir/ig/gravitate-health/SubstanceDefinition/substance-hypericumperforatumwhole
    l: substance-hypericumperforatumwhole
  resource: substance-hypericumperforatumwhole
entry:
  full url:
    v: http://hl7.eu/fhir/ig/gravitate-health/AdministrableProductDefinition/ap-29436a85dac3ea374adb3fa64cfd2578
entry:
  full url:
    v: http://hl7.eu/fhir/ig/gravitate-health/RegulatedAuthorization/authorization29436a85dac3ea374adb3fa64cfd25780
entry:
  full url:
    v: http://hl7.eu/fhir/ig/gravitate-health/Organization/mah-c2a5378488511eaedce26dde272c2290
entry:
  full url:
    v: http://hl7.eu/fhir/ig/gravitate-health/PackagedProductDefinition/ppd-ee8bd93e975dcd04f4824ba8d24a8944
entry:
  full url:
    v: http://hl7.eu/fhir/ig/gravitate-health/MedicinalProductDefinition/mpaf8d2f6e4772c29a8ef9fbb165e80d28
    l: mpaf8d2f6e4772c29a8ef9fbb165e80d28
  resource: mpaf8d2f6e4772c29a8ef9fbb165e80d28
entry:
  full url:
    v: http://hl7.eu/fhir/ig/gravitate-health/ManufacturedItemDefinition/mid-29436a85dac3ea374adb3fa64cfd2578

http://hl7.eu/fhir/ig/gravitate-health/Composition/composition-en-af8d2f6e4772c29a8ef9fbb165e80d28
type: Composition
meta:
  profile:
    v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Composition-uv-epi
    l: Composition-uv-epi
language:
  v: en
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Composition composition-en-af8d2f6e4772c29a8ef9fbb165e80d28 Language: en Profile: Composition (ePI) identifier: https://spor.ema.europa.eu/rmswi//79963 status: Final type: Package Leaflet category: Raw date: 2022-02-16 13:28:17+0000 author: Organization Arkopharma LABORATORIOS, S.A.U, title: TEST PURPOSES ONLY - HIPÉRICO ARKOPHARMA cápsulas duras Attesters - Mode Time * Official 2022-02-16 13:28:17+0000
identifier:
  system:
    v: https://spor.ema.europa.eu/rmswi/
    l: rmswi
  value:
    v: 79963
status:
  v: final
type:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi/
      l: rmswi
    code:
      v: 100000155538
  text:
    v: Package Leaflet
category:
  coding:
    system:
      v: http://hl7.eu/fhir/ig/gravitate-health/CodeSystem/epicategory-cs
      l: epicategory-cs
    code:
      v: R
    display:
      v: Raw
subject:
  l: mpaf8d2f6e4772c29a8ef9fbb165e80d28
date:
  v: 2022-02-16T13:28:17Z
title:
  v: TEST PURPOSES ONLY - HIPÉRICO ARKOPHARMA cápsulas duras
attester:
  mode:
    coding:
      system:
        v: http://hl7.org/fhir/composition-attestation-mode
        l: composition-attestation-mode
      code:
        v: official
  time:
    v: 2022-02-16T13:28:17Z
section:
  title:
    v: B. Package Leaflet
  code:
    coding:
      system:
        v: https://spor.ema.europa.eu/rmswi/
        l: rmswi
      code:
        v: 100000155538
    text:
      v: B. Package Leaflet
  text:
    status:
      v: additional
    div:
      v: unavailable
  empty reason:
    coding:
      system:
        v: http://terminology.hl7.org/CodeSystem/list-empty-reason
        l: list-empty-reason
      code:
        v: unavailable
  section:
    title:
      v: Package leaflet: Information for the user
    code:
      text:
        v: Package leaflet: Information for the user
    text:
      status:
        v: additional
      div:
        v: LEAFLET: INFORMATION FOR THE USER HYPERICUM ARKOPHARMA hard capsules Hypericum perforatum L. Read the entire leaflet carefully before you start taking this medicine, as it contains important information for you. Follow the exact administration instructions contained in this leaflet or as directed by your pharmacist, doctor, or nurse. - Keep this leaflet, as you may need to read it again. - If you need advice or more information, consult your pharmacist. - If you experience adverse effects, consult your doctor, pharmacist, or nurse, even if they are not listed in this leaflet. - You should consult a doctor if your condition worsens or does not improve after 28 days of treatment.
  section:
    title:
      v: What is in this leaflet
    code:
      text:
        v: What is in this leaflet
    text:
      status:
        v: additional
      div:
        v: Contents of the leaflet 1. What HYPERICUM ARKOPHARMA is and what it is used for 2. What you need to know before you start taking HYPERICUM ARKOPHARMA 3. How to take HYPERICUM ARKOPHARMA 4. Possible side effects 5. Storage of HYPERICUM ARKOPHARMA 6. Package contents and additional information.
  section:
    title:
      v: 1. What HIPÉRICO ARKOPHARMA hard capsules is and what it is used for
    code:
      text:
        v: 1. What HIPÉRICO ARKOPHARMA hard capsules is and what it is used for
    text:
      status:
        v: additional
      div:
        v: Herbal medicine for the symptomatic treatment of low mood, lack of interest, fatigue, and sleep disturbances. You should consult a doctor if your condition worsens or does not improve after 28 days.
  section:
    title:
      v: 2. What you need to know before you take HIPÉRICO ARKOPHARMA hard capsules
    code:
      text:
        v: 2. What you need to know before you take HIPÉRICO ARKOPHARMA hard capsules
    text:
      status:
        v: additional
      div:
        v: Do not take HYPERICUM ARKOPHARMA If you are under 18 years old. If you are pregnant or breastfeeding. If you are allergic to Hypericum perforatum L. or any of the components of the medicine. If you are undergoing surgery requiring treatment with other medications. If you are being treated with any of the medicines listed in this leaflet. Some components of hypericum (Hypericum perforatum L.) can cause pharmacokinetic interactions with numerous medicines, potentially reducing their effectiveness (see information on taking other medicines). Warnings and precautions Consult your pharmacist, doctor, or nurse before starting HYPERICUM ARKOPHARMA. If you are taking HYPERICUM ARKOPHARMA, avoid intense UV exposure (prolonged sun exposure or tanning beds). Women using oral contraceptives should not use this medicine simultaneously, as it may cause intermenstrual bleeding and reduce the effectiveness of contraceptives. Avoid intense solar radiation or artificial ultraviolet radiation while taking this medicine. Its use is not recommended during phototherapy treatments (UVA light therapy) or if undergoing any photodiagnostic tests, particularly in light-skinned individuals, as it may cause sunburn-like reactions on exposed skin. If you have been diagnosed with depression and are being treated with psychotropic drugs, selective serotonin reuptake inhibitors, or triptans, do not use this medicine. Stop taking this medicine 10 days before surgery or any planned clinical intervention to avoid potential interactions with other medicines during general or local anesthesia. Children and adolescents Children and adolescents under 18 years should not use this medicine. Use of HYPERICUM ARKOPHARMA with other medicines Some components of hypericum (Hypericum perforatum L.) may reduce the therapeutic effects of other medicines when taken simultaneously. These include medicines recommended by your doctor and over-the-counter medications. Patients taking the following medicines should not s…
  section:
    title:
      v: 3. How to take HIPÉRICO ARKOPHARMA hard capsules
    code:
      text:
        v: 3. How to take HIPÉRICO ARKOPHARMA hard capsules
    text:
      status:
        v: additional
      div:
        v: Follow the administration instructions for the medicine as described in this leaflet or as directed by your pharmacist, doctor, or nurse. If in doubt, consult your pharmacist, doctor, or nurse. The recommended dose is: Adults: take 2 capsules, 2 or 3 times a day with a glass of water. It is advisable to take the doses at the same times every day. This medicine is for oral use. The treatment duration is 6 weeks. The effect of the medicine usually appears after 4 weeks. If symptoms persist, you should consult a healthcare professional. Once the package is opened, remove the absorbent sachet, which is not suitable for human consumption and must not be ingested. Use in children and adolescents Do not use in children and adolescents under 18 years of age. If you take more HYPERICUM ARKOPHARMA than you should If you have taken an excessive dose of HYPERICUM ARKOPHARMA, seizures or confusion may occur. In case of an excessive dose of hypericum, protect yourself from sunlight or any other UV ray source for 1-2 weeks. In case of overdose or accidental ingestion, immediately consult your pharmacist or doctor, or call the Toxicology Information Service at 91 562 04 20, indicating the product and the quantity ingested. If you forget to take HYPERICUM ARKOPHARMA If you forget a dose, take the medicine as soon as possible and continue the treatment as prescribed. However, if it is close to the time for the next dose, it is better to skip the missed dose and wait for the next one. Never take a double dose to make up for the missed dose..
  section:
    title:
      v: 4. Possible side effects
    code:
      text:
        v: 4. Possible side effects
    text:
      status:
        v: additional
      div:
        v: Like all medicines, this medicine can cause side effects, although not everyone will experience them. In rare cases, with a frequency affecting fewer than one in 1000 patients, digestive problems such as nausea, abdominal pain, diarrhea, loss of appetite, or skin reactions such as itching, irritation, redness (hives), and very rarely, sunburn-like reactions on skin exposed to intense sunlight or artificial radiation have been reported. Headache, neuropathy, anxiety, dizziness, fatigue, mania, or allergies have also been reported, but the frequency of these occurrences is unknown. Reporting adverse reactions: If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Medicines for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information about the safety of this medicine.
  section:
    title:
      v: 5. How to store HIPÉRICO ARKOPHARMA hard capsules
    code:
      text:
        v: 5. How to store HIPÉRICO ARKOPHARMA hard capsules
    text:
      status:
        v: additional
      div:
        v: Keep this medicine out of the sight and reach of children. Do not store at a temperature above 25ºC. Once opened, discard after 21 days. Do not use HYPERICUM ARKOPHARMA after the expiration date stated on the package, following the abbreviation “EXP.” The expiration date refers to the last day of the indicated month. Medicines should not be disposed of via wastewater or household waste. Take unused packages and medicines to the SIGRE Point at the pharmacy. If in doubt, ask your pharmacist how to dispose of medicines and packaging you no longer need. This will help protect the environment.
  section:
    title:
      v: 6. Contents of the pack and other information
    code:
      text:
        v: 6. Contents of the pack and other information
    text:
      status:
        v: additional
      div:
        v: Composition of HYPERICUM ARKOPHARMA Each capsule contains the active ingredient: 175 mg of hydroalcoholic dry extract of Hypericum perforatum L. herba (flowering tops of St. John's wort) (3.5-6:1) corresponding to: 0.27 mg to 0.46 mg of total hypericins, ≥ 10.5 mg of flavonoids, and 2.71 mg to 4.63 mg of hyperforin. Extraction solvent: ethanol 60% m/m Other ingredients (excipients): microcrystalline cellulose, magnesium stearate, colloidal anhydrous silica, and maltodextrin. Capsule composition: hypromellose, titanium dioxide, and yellow iron oxide. Product appearance and package contents There is one presentation in bottles containing 42 capsules, with an absorbent sachet inside. Once the container is opened, the absorbent sachet should be removed, as it is not suitable for human consumption and must not be ingested. Marketing authorization holder and manufacturer: Holder Arkopharma LABORATORIES, S.A.U, C/ Amaltea, 9 28045 MADRID Manufacturer ARKOPHARMA LABORATOIRES PHARMACEUTIQUES BP 28 – 06511 CARROS Cedex - FRANCE Date of the last revision of this leaflet: September 2016 Detailed and updated information about this medicine is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/

ingredient-for-hipricoarkopharma-hypericumperforatuml
type: Ingredient
id:
  v: ingredient-for-hipricoarkopharma-hypericumperforatuml
meta:
  profile:
    v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi
    l: Ingredient-uv-epi
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Ingredient ingredient-for-hipricoarkopharma-hypericumperforatuml Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/XK4IUX8MNB (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#79963 (use: official, ); status = active; manufacturedDoseForm = hard capsules; unitOfPresentation = hard capsules MedicinalProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#79963; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#xx; status = active; administrableDoseForm = Hard capsules; unitOfPresentation = hard capsule role: active substance Codes - Concept * Hypericum perforatum L. Strengths - Presentation[x] Basis * 175 mg (Details: UCUM codemg = 'mg') active ingredient - basis of strength
identifier:
  use:
    v: official
  system:
    v: https://gsrs.ncats.nih.gov/ginas/app/beta
    l: beta
  value:
    v: XK4IUX8MNB
status:
  v: active
for:
  l: mpaf8d2f6e4772c29a8ef9fbb165e80d28
role:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi
      l: rmswi
    code:
      v: 72072
    display:
      v: active
substance:
  strength:
    presentation: Quantity
      value:
        v: 175
      system:
        v: http://unitsofmeasure.org
        l: unitsofmeasure.org
      code:
        v: mg

ingredient-for-hipricoarkopharma-microcrystallinecellulose
type: Ingredient
id:
  v: ingredient-for-hipricoarkopharma-microcrystallinecellulose
meta:
  profile:
    v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi
    l: Ingredient-uv-epi
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Ingredient ingredient-for-hipricoarkopharma-microcrystallinecellulose Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/OP1R32D61U (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#79963 (use: official, ); status = active; manufacturedDoseForm = hard capsules; unitOfPresentation = hard capsules MedicinalProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#79963; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#xx; status = active; administrableDoseForm = Hard capsules; unitOfPresentation = hard capsule role: excipient substance Codes - Concept * microcrystalline cellulose
identifier:
  use:
    v: official
  system:
    v: https://gsrs.ncats.nih.gov/ginas/app/beta
    l: beta
  value:
    v: OP1R32D61U
status:
  v: active
for:
  l: mpaf8d2f6e4772c29a8ef9fbb165e80d28
role:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi
      l: rmswi
    code:
      v: 100000072082
    display:
      v: excipient

ingredient-for-hipricoarkopharma-magnesiumstearate
type: Ingredient
id:
  v: ingredient-for-hipricoarkopharma-magnesiumstearate
meta:
  profile:
    v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi
    l: Ingredient-uv-epi
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Ingredient ingredient-for-hipricoarkopharma-magnesiumstearate Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/70097M6I30 (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#79963 (use: official, ); status = active; manufacturedDoseForm = hard capsules; unitOfPresentation = hard capsules MedicinalProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#79963; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#xx; status = active; administrableDoseForm = Hard capsules; unitOfPresentation = hard capsule role: excipient substance Codes - Concept * magnesium stearate
identifier:
  use:
    v: official
  system:
    v: https://gsrs.ncats.nih.gov/ginas/app/beta
    l: beta
  value:
    v: 70097M6I30
status:
  v: active
for:
  l: mpaf8d2f6e4772c29a8ef9fbb165e80d28
role:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi
      l: rmswi
    code:
      v: 100000072082
    display:
      v: excipient

ingredient-for-hipricoarkopharma-colloidalhydrophobicsilica
type: Ingredient
id:
  v: ingredient-for-hipricoarkopharma-colloidalhydrophobicsilica
meta:
  profile:
    v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi
    l: Ingredient-uv-epi
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Ingredient ingredient-for-hipricoarkopharma-colloidalhydrophobicsilica Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/8MDF5V39QO (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#79963 (use: official, ); status = active; manufacturedDoseForm = hard capsules; unitOfPresentation = hard capsules MedicinalProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#79963; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#xx; status = active; administrableDoseForm = Hard capsules; unitOfPresentation = hard capsule role: excipient substance Codes - Concept * colloidal hydrophobic silica
identifier:
  use:
    v: official
  system:
    v: https://gsrs.ncats.nih.gov/ginas/app/beta
    l: beta
  value:
    v: 8MDF5V39QO
status:
  v: active
for:
  l: mpaf8d2f6e4772c29a8ef9fbb165e80d28
role:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi
      l: rmswi
    code:
      v: 100000072082
    display:
      v: excipient

ingredient-for-hipricoarkopharma-maltodextrin
type: Ingredient
id:
  v: ingredient-for-hipricoarkopharma-maltodextrin
meta:
  profile:
    v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi
    l: Ingredient-uv-epi
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Ingredient ingredient-for-hipricoarkopharma-maltodextrin Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/7CVR7L4A2D (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#79963 (use: official, ); status = active; manufacturedDoseForm = hard capsules; unitOfPresentation = hard capsules MedicinalProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#79963; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#xx; status = active; administrableDoseForm = Hard capsules; unitOfPresentation = hard capsule role: excipient substance Codes - Concept * maltodextrin
identifier:
  use:
    v: official
  system:
    v: https://gsrs.ncats.nih.gov/ginas/app/beta
    l: beta
  value:
    v: 7CVR7L4A2D
status:
  v: active
for:
  l: mpaf8d2f6e4772c29a8ef9fbb165e80d28
role:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi
      l: rmswi
    code:
      v: 100000072082
    display:
      v: excipient

substance-hypericumperforatumwhole
type: SubstanceDefinition
id:
  v: substance-hypericumperforatumwhole
meta:
  profile:
    v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/SubstanceDefinition-uv-epi
    l: SubstanceDefinition-uv-epi
text:
  status:
    v: generated
  div:
    v: Generated Narrative: SubstanceDefinition substance-hypericumperforatumwhole Profile: SubstanceDefinition (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta//XK4IUX8MNB (use: official, ) version: 1 status: Active manufacturer: Organization Arkopharma LABORATORIOS, S.A.U, MolecularWeights - Type Amount * exact 156.09 Structures - MolecularFormula * C35H52O4 Names - Name Type * Hyperforin Chemical Name
identifier:
  use:
    v: official
  system:
    v: https://gsrs.ncats.nih.gov/ginas/app/beta/
    l: beta
  value:
    v: XK4IUX8MNB
version:
  v: 1
status:
  coding:
    system:
      v: http://hl7.org/fhir/publication-status
      l: publication-status
    code:
      v: active
molecular weight:
  type:
    text:
      v: exact
  amount:
    value:
      v: 156.09
structure:
  molecular formula:
    v: C35H52O4
name:
  name:
    v: Hyperforin
  type:
    coding:
      system:
        v: https://gsrs.ncats.nih.gov/ginas/app/beta/
        l: beta
      code:
        v: x
      display:
        v: Chemical Name

http://hl7.eu/fhir/ig/gravitate-health/AdministrableProductDefinition/ap-29436a85dac3ea374adb3fa64cfd2578
type: AdministrableProductDefinition
meta:
  profile:
    v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/AdministrableProductDefinition-uv-epi
    l: AdministrableProductDefinition-uv-epi
text:
  status:
    v: generated
  div:
    v: Generated Narrative: AdministrableProductDefinition ap-29436a85dac3ea374adb3fa64cfd2578 Profile: AdministrableProductDefinition (ePI) identifier: https://spor.ema.europa.eu/pmswi/xx status: Active formOf: MedicinalProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#79963; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription administrableDoseForm: Hard capsules unitOfPresentation: hard capsule producedFrom: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#79963 (use: official, ); status = active; manufacturedDoseForm = hard capsules; unitOfPresentation = hard capsules routeOfAdministration code: Oral use TargetSpecies - Code * Human
identifier:
  system:
    v: https://spor.ema.europa.eu/pmswi
    l: pmswi
  value:
    v: xx
status:
  v: active
form of:
  l: mpaf8d2f6e4772c29a8ef9fbb165e80d28
administrable dose form:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi
      l: rmswi
    code:
      v: 100000073681
    display:
      v: Hard capsules
unit of presentation:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi
      l: rmswi
    code:
      v: 200000002152
    display:
      v: hard capsule
route of administration:
  code:
    coding:
      system:
        v: https://spor.ema.europa.eu/rmswi
        l: rmswi
      code:
        v: 100000073619
      display:
        v: Oral use

http://hl7.eu/fhir/ig/gravitate-health/RegulatedAuthorization/authorization29436a85dac3ea374adb3fa64cfd25780
type: RegulatedAuthorization
meta:
  profile:
    v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/RegulatedAuthorization-uv-epi
    l: RegulatedAuthorization-uv-epi
text:
  status:
    v: generated
  div:
    v: Generated Narrative: RegulatedAuthorization authorization29436a85dac3ea374adb3fa64cfd25780 Profile: RegulatedAuthorization (ePI) identifier: https://spor.ema.europa.eu/pmswi/79963 (use: official, ) subject: MedicinalProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#79963; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription type: Marketing Authorisation status: Active statusDate: 2015-01-01 holder: Organization Arkopharma LABORATORIOS, S.A.U,
identifier:
  use:
    v: official
  system:
    v: https://spor.ema.europa.eu/pmswi
    l: pmswi
  value:
    v: 79963
subject:
  l: mpaf8d2f6e4772c29a8ef9fbb165e80d28
type:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi
      l: rmswi
    code:
      v: 100000072062
    display:
      v: Marketing Authorisation
status:
  coding:
    system:
      v: http://hl7.org/fhir/publication-status
      l: publication-status
    code:
      v: active
    display:
      v: Active
status date:
  v: 2015-01-01

http://hl7.eu/fhir/ig/gravitate-health/Organization/mah-c2a5378488511eaedce26dde272c2290
type: Organization
meta:
  profile:
    v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Organization-uv-epi
    l: Organization-uv-epi
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Organization mah-c2a5378488511eaedce26dde272c2290 Profile: Organization (ePI) identifier: https://spor.ema.europa.eu/omswi/xx (use: official, ) active: true type: Marketing authorisation holder name: Arkopharma LABORATORIOS, S.A.U, Contacts - Address * C/ Amaltea, 9 Madrid ES(work)
identifier:
  use:
    v: official
  system:
    v: https://spor.ema.europa.eu/omswi
    l: omswi
  value:
    v: xx
active:
  v: true
type:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi
      l: rmswi
    code:
      v: 220000000034
    display:
      v: Marketing authorisation holder
name:
  v: Arkopharma LABORATORIOS, S.A.U,
contact:
  address:
    use:
      v: work
    type:
      v: physical
    text:
      v: C/ Amaltea, 9 Madrid ES
    line:
      v: C/ Amaltea, 9
    city:
      v: Madrid
    postal code:
      v: 28045
    country:
      v: ES

http://hl7.eu/fhir/ig/gravitate-health/PackagedProductDefinition/ppd-ee8bd93e975dcd04f4824ba8d24a8944
type: PackagedProductDefinition
meta:
  profile:
    v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi
    l: PackagedProductDefinition-uv-epi
text:
  status:
    v: generated
  div:
    v: Generated Narrative: PackagedProductDefinition ppd-ee8bd93e975dcd04f4824ba8d24a8944 Profile: PackagedProductDefinition (ePI) identifier: https://spor.ema.europa.eu/pmswi/x (use: official, ) name: HIPÉRICO ARKOPHARMA cápsulas duras 30 type: Chemical Medicinal Prodcut packageFor: MedicinalProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#79963; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription status: Active statusDate: 2015-01-03 containedItemQuantity: 175 mg (Details: UCUM codemg = 'mg') copackagedIndicator: false packaging type: Box quantity: 1 material: Cardboard packaging identifier: https://spor.ema.europa.eu/pmswi/123456 type: Blister quantity: 30 material: cardboard containedItem Items - Reference * ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#79963 (use: official, ); status = active; manufacturedDoseForm = hard capsules; unitOfPresentation = hard capsules
identifier:
  use:
    v: official
  system:
    v: https://spor.ema.europa.eu/pmswi
    l: pmswi
  value:
    v: x
name:
  v: HIPÉRICO ARKOPHARMA cápsulas duras 30
type:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi
      l: rmswi
    code:
      v: 100000155527
    display:
      v: Chemical Medicinal Prodcut
package for:
  l: mpaf8d2f6e4772c29a8ef9fbb165e80d28
status:
  coding:
    system:
      v: http://hl7.org/fhir/publication-status
      l: publication-status
    code:
      v: active
    display:
      v: Active
status date:
  v: 2015-01-03
contained item quantity:
  value:
    v: 175
  system:
    v: http://unitsofmeasure.org
    l: unitsofmeasure.org
  code:
    v: mg
copackaged indicator:
  v: false
packaging:
  type:
    coding:
      system:
        v: https://spor.ema.europa.eu/rmswi
        l: rmswi
      code:
        v: 100000073498
      display:
        v: Box
  quantity:
    v: 1
  material:
    coding:
      system:
        v: https://spor.ema.europa.eu/rmswi
        l: rmswi
      code:
        v: 200000003529
      display:
        v: Cardboard
  packaging:
    identifier:
      system:
        v: https://spor.ema.europa.eu/pmswi
        l: pmswi
      value:
        v: 123456
    quantity:
      v: 30

mpaf8d2f6e4772c29a8ef9fbb165e80d28
type: MedicinalProductDefinition
id:
  v: mpaf8d2f6e4772c29a8ef9fbb165e80d28
meta:
  profile:
    v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/MedicinalProductDefinition-uv-epi
    l: MedicinalProductDefinition-uv-epi
text:
  status:
    v: generated
  div:
    v: Generated Narrative: MedicinalProductDefinition mpaf8d2f6e4772c29a8ef9fbb165e80d28 Profile: MedicinalProductDefinition (ePI) identifier: https://spor.ema.europa.eu/pmswi/79963 type: Medicinal Product domain: Human use status: active legalStatusOfSupply: Medicinal product subject to medical prescription name productName: HIPÉRICO ARKOPHARMA cápsulas duras type: Full name part part: HIPÉRICO ARKOPHARMA type: Invented name part part part: Hypericum perforatum L. type: Scientific name part part part: 175 mg type: Strength part part part: hard capsules type: Pharmaceutical dose form part Usages - Country Jurisdiction Language * Spain Spain English
identifier:
  system:
    v: https://spor.ema.europa.eu/pmswi
    l: pmswi
  value:
    v: 79963
type:
  coding:
    system:
      v: http://hl7.org/fhir/medicinal-product-type
      l: medicinal-product-type
    code:
      v: MedicinalProduct
    display:
      v: Medicinal Product
domain:
  coding:
    system:
      v: http://hl7.org/fhir/medicinal-product-domain
      l: medicinal-product-domain
    code:
      v: Human
    display:
      v: Human use
status:
  coding:
    system:
      v: http://hl7.org/fhir/publication-status
      l: publication-status
    code:
      v: active
    display:
      v: active
legal status of supply:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi
      l: rmswi
    code:
      v: 100000000000
    display:
      v: Medicinal product subject to medical prescription
name:
  product name:
    v: HIPÉRICO ARKOPHARMA cápsulas duras
  type:
    coding:
      system:
        v: https://spor.ema.europa.eu/lists/220000000000
        l: https://spor.ema.europa.eu/lists/220000000000
      code:
        v: 220000000001
      display:
        v: Full name
  part:
    part:
      v: HIPÉRICO ARKOPHARMA
  part:
    part:
      v: Hypericum perforatum L.
  part:
    part:
      v: 175 mg
  part:
    part:
      v: hard capsules

http://hl7.eu/fhir/ig/gravitate-health/ManufacturedItemDefinition/mid-29436a85dac3ea374adb3fa64cfd2578
type: ManufacturedItemDefinition
meta:
  profile:
    v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ManufacturedItemDefinition-uv-epi
    l: ManufacturedItemDefinition-uv-epi
text:
  status:
    v: generated
  div:
    v: Generated Narrative: ManufacturedItemDefinition mid-29436a85dac3ea374adb3fa64cfd2578 Profile: ManufacturedItemDefinition (ePI) identifier: https://spor.ema.europa.eu/pmswi/79963 (use: official, ) status: Active manufacturedDoseForm: hard capsules unitOfPresentation: hard capsules
identifier:
  use:
    v: official
  system:
    v: https://spor.ema.europa.eu/pmswi
    l: pmswi
  value:
    v: 79963
status:
  v: active
manufactured dose form:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi/
      l: rmswi
    code:
      v: 100000073681
    display:
      v: hard capsules
unit of presentation:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi
      l: rmswi
    code:
      v: 200000002152
    display:
      v: hard capsules

v: 100000155538

v: 100000155538

v: 100000155538

v: 100000155538

v: 100000155538

v: 100000155538

v: 100000155538

v: 100000155538

v: XK4IUX8MNB

v: Hypericum perforatum L.

v: ACTIB

v: active ingredient - basis of strength

v: OP1R32D61U

v: microcrystalline cellulose

v: 70097M6I30

v: magnesium stearate

v: 8MDF5V39QO

v: colloidal hydrophobic silica

v: 7CVR7L4A2D

v: maltodextrin

v: 100000109093

v: Human

v: 100000073496

v: Blister

v: xxx

v: cardboard

v: 220000000002

v: Invented name part

v: 220000000003

v: Scientific name part

v: 220000000004

v: Strength part

v: 220000000005

v: Pharmaceutical dose form part

v: urn:iso:std:iso:3166
l: 3166

v: ES

v: urn:iso:std:iso:3166
l: 3166

v: ES

v: urn:ietf:bcp:47
l: 47

v: en

v: English